Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial

Salmon-Céron, Dominique; Durier, Christine; Desaint, Corinne; More

AIDS . 24(14):2211-2223, September 10, 2010.

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy

Salmon-Céron, Dominique; Mazeron, Marie-Christine; Chaput, Sophie; More

AIDS . 14(8):1041-1049, May 26, 2000.